OR WAIT null SECS
Quintiles announced the release of Quintiles Infosario, a business-to-business platform that enables customers to leverage data for improved collaboration and decision-making throughout the drug development process.
“Quintiles Infosario is a fully integrated platform that enables significant advances in the drug development process,” said Tom Grundstrom, Quintiles Infosario Global Head. “The technology makes it possible to turn the wealth of data that our company possesses into actionable insights for our customers. Through the platform’s intuitive user interface, key stakeholders will be able to make faster, better-informed decisions about the programs and therapies they are working on.”
Quintiles’ latest reporting and analytics technology integrates, synchronizes, and standardizes subject, operational and management data automatically across a multitude of systems. The platform transforms data and information into meaningful insights to Quintiles’ customers using a secure, web-based front end with a drill path from insight to clinical data. Quintiles Infosario’s reporting and analytics capabilities are among the first features that will be available to select customers beginning later this month.
In addition, customers can fulfill all or parts of their clinical IT system needs through Quintiles Infosario’s cloud-based Systems as a Service. Infosario combines IT provisioning, including configured systems with core clinical business process delivery. By using Systems as a Service, customers will have direct, cost-effective access to IT systems such as safety management and clinical trial management–the same systems that serve Quintiles business.